KRRO Price / Book | Korro Bio, Inc.

Korro Bio, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

Korro Bio, Inc. price/book ratio for the quarter ending 2026-06-30 was 1.87, a 81.24% increase year-over-year.
Korro Bio, Inc. price/book ratio for the quarter ending 2026-03-31 was 1.36, a 16.01% increase year-over-year.
Korro Bio, Inc. price/book ratio for the quarter ending 2025-12-31 was 1.47, a 34.11% decline year-over-year.
Korro Bio, Inc. price/book ratio for the quarter ending 2025-09-30 was 4.52, a 160.94% increase year-over-year.
Korro Bio, Inc. price/book ratio for fiscal 2026 was 1.87.
Korro Bio, Inc. price/book ratio for fiscal 2025 was 1.47, a 34.11% decline from fiscal 2024.
Korro Bio, Inc. price/book ratio for fiscal 2024 was 2.23, a 1.59% decline from fiscal 2023.
Korro Bio, Inc. price/book ratio for fiscal 2023 was 2.26, a change of 2.78 from fiscal 2022.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.87	$193.09M	$103.23M
2026-03-31	1.36	$163.26M	$119.63M
2025-12-31	1.47	$75.43M	$51.44M
2025-09-30	4.52	$448M	$99.03M
2025-06-30	1.03	$118.79M	$115.1M
2025-03-31	1.18	$163.46M	$138.96M
2024-12-31	2.23	$356.99M	$160.42M
2024-09-30	1.73	$311.42M	$179.63M
2024-06-30	1.59	$314.31M	$198.08M
2024-03-31	4.77	$722.02M	$151.36M
2023-12-31	2.26	$384.23M	$169.91M
2023-09-30	-4.46	$683.14M	-$153.26M
2023-06-30	-4.6	$622.17M	-$135.4M
2023-03-31	-7.61	$899.16M	-$118.23M
2022-12-31	-0.52	$51.68M	-$99.03M
2022-09-30	38.5	$3.16B	$81.97M
2022-06-30	27.37	$2.62B	$95.85M
2022-03-31	32.91	$3.71B	$112.67M
2021-12-31	-210.33	$8.88B	-$42.21M
2021-09-30	82.91	$12.2B	$147.12M
2021-06-30	103.13	$17.12B	$166.04M
2021-03-31	91.61	$16.25B	$177.41M
2020-12-31	311.07	$59.88B	$192.49M
2020-09-30	162.33	$32.4B	$199.59M
2020-06-30	224.66	$36.33B	$161.7M
2020-03-31	167.51	$27.61B	$164.85M
2019-12-31	161.54	$27.04B	$167.36M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	1.87	$193.09M	$103.23M
2025-12-31	1.47	$75.43M	$51.44M
2024-12-31	2.23	$356.99M	$160.42M
2023-12-31	2.26	$384.23M	$169.91M
2022-12-31	-0.52	$51.68M	-$99.03M
2021-12-31	-210.33	$8.88B	-$42.21M
2020-12-31	311.07	$59.88B	$192.49M
2019-12-31	161.54	$27.04B	$167.36M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Atrium Therapeutics, Inc. (RNA)	United States	$0.140B
SPRUCE BIOSCIENCES, INC. (SPRB)	United States	$0.142B	-2.89
Curanex Pharmaceuticals Inc (CURX)	United States	$0.138B
Corbus Pharmaceuticals Holdings, Inc. (CRBP)	United States	$0.144B	-1.72
Annexon, Inc. (ANNX)	United States	$0.147B	-4.22
TuHURA Biosciences, Inc./NV (HURA)	United States	$0.134B	-4.88
Unicycive Therapeutics, Inc. (UNCY)	United States	$0.134B	-3.70
NRX Pharmaceuticals, Inc. (NRXP)	United States	$0.131B	-6.31
MEDICINOVA INC (MNOV)	United States	$0.130B	-6.04
IMMUNIC, INC. (IMUX)	United States	$0.127B	-1.88